Aptose Biosciences Stock Market Value
| APTO Stock | USD 3.69 0.09 2.38% |
| Symbol | Aptose |
Aptose Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aptose Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aptose Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aptose Biosciences.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Aptose Biosciences on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Aptose Biosciences or generate 0.0% return on investment in Aptose Biosciences over 90 days. Aptose Biosciences is related to or competes with CytomX Therapeutics, Instil Bio, Spero Therapeutics, Assembly Biosciences, Fortress Biotech, Mustang Bio, and Achilles Therapeutics. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressin... More
Aptose Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aptose Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aptose Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0) | |||
| Maximum Drawdown | 87.0 | |||
| Value At Risk | (13.74) | |||
| Potential Upside | 15.06 |
Aptose Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aptose Biosciences' standard deviation. In reality, there are many statistical measures that can use Aptose Biosciences historical prices to predict the future Aptose Biosciences' volatility.| Risk Adjusted Performance | (0.000068) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | 1.32 | |||
| Treynor Ratio | 0.4129 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptose Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aptose Biosciences Backtested Returns
Aptose Biosciences secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Aptose Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptose Biosciences' Standard Deviation of 11.58, mean deviation of 6.67, and Risk Adjusted Performance of (0.000068) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Aptose Biosciences are expected to decrease at a much lower rate. During the bear market, Aptose Biosciences is likely to outperform the market. At this point, Aptose Biosciences has a negative expected return of -0.0803%. Please make sure to confirm Aptose Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Aptose Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Aptose Biosciences has average predictability. Overlapping area represents the amount of predictability between Aptose Biosciences time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aptose Biosciences price movement. The serial correlation of 0.46 indicates that about 46.0% of current Aptose Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 1.41 |
Aptose Biosciences lagged returns against current returns
Autocorrelation, which is Aptose Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aptose Biosciences' stock expected returns. We can calculate the autocorrelation of Aptose Biosciences returns to help us make a trade decision. For example, suppose you find that Aptose Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aptose Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aptose Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aptose Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aptose Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Aptose Biosciences Lagged Returns
When evaluating Aptose Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aptose Biosciences stock have on its future price. Aptose Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aptose Biosciences autocorrelation shows the relationship between Aptose Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Aptose Biosciences.
Regressed Prices |
| Timeline |
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Aptose Stock
| 0.65 | ENVB | Enveric Biosciences Earnings Call This Week | PairCorr |
Moving against Aptose Stock
| 0.85 | IVA | Inventiva Sa | PairCorr |
| 0.7 | LLY | Eli Lilly | PairCorr |
| 0.62 | PBH | Prestige Brand Holdings | PairCorr |
| 0.62 | KRYS | Krystal Biotech | PairCorr |
| 0.5 | VIGL | Vigil Neuroscience | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aptose Biosciences Correlation, Aptose Biosciences Volatility and Aptose Biosciences Alpha and Beta module to complement your research on Aptose Biosciences. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Aptose Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.